Manitou Investment Management Ltd. Buys 203 Shares of CME Group Inc. (NASDAQ:CME)

Manitou Investment Management Ltd. boosted its stake in shares of CME Group Inc. (NASDAQ:CME) by 7.1% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 3,060 shares of the financial services provider’s stock after acquiring an additional 203 shares during the quarter. CME Group makes up approximately 0.1% of Manitou Investment Management Ltd.’s holdings, making the stock its 22nd biggest holding. Manitou Investment Management Ltd.’s holdings in CME Group were worth $675,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Capital International Investors boosted its stake in shares of CME Group by 24.1% in the 1st quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock valued at $3,403,557,000 after purchasing an additional 3,069,806 shares during the last quarter. PineStone Asset Management Inc. boosted its stake in shares of CME Group by 137.6% in the 2nd quarter. PineStone Asset Management Inc. now owns 2,260,644 shares of the financial services provider’s stock valued at $444,443,000 after purchasing an additional 1,309,097 shares during the last quarter. M&G Plc bought a new position in shares of CME Group in the 1st quarter valued at about $156,631,000. Assenagon Asset Management S.A. boosted its stake in CME Group by 577.9% during the 2nd quarter. Assenagon Asset Management S.A. now owns 645,330 shares of the financial services provider’s stock worth $126,872,000 after acquiring an additional 550,133 shares during the last quarter. Finally, Ameriprise Financial Inc. boosted its stake in CME Group by 11.3% during the 2nd quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider’s stock worth $1,038,676,000 after acquiring an additional 537,758 shares during the last quarter. Institutional investors own 87.75% of the company’s stock.

Insider Activity at CME Group

In related news, insider Sunil Cutinho sold 4,500 shares of the business’s stock in a transaction dated Wednesday, October 30th. The stock was sold at an average price of $226.64, for a total value of $1,019,880.00. Following the completion of the transaction, the insider now owns 27,053 shares of the company’s stock, valued at $6,131,291.92. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In other CME Group news, insider Sunil Cutinho sold 4,500 shares of the business’s stock in a transaction dated Wednesday, October 30th. The stock was sold at an average price of $226.64, for a total transaction of $1,019,880.00. Following the completion of the transaction, the insider now owns 27,053 shares of the company’s stock, valued at approximately $6,131,291.92. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Timothy Francis Mccourt sold 1,374 shares of the business’s stock in a transaction dated Monday, October 28th. The stock was sold at an average price of $227.12, for a total value of $312,062.88. Following the transaction, the insider now directly owns 7,275 shares of the company’s stock, valued at approximately $1,652,298. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 15,221 shares of company stock valued at $3,351,895 over the last quarter. 0.30% of the stock is owned by corporate insiders.

CME Group Trading Down 0.8 %

CME stock opened at $225.36 on Friday. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.02 and a quick ratio of 1.02. The company has a fifty day moving average price of $220.36 and a two-hundred day moving average price of $209.34. CME Group Inc. has a one year low of $190.70 and a one year high of $230.36. The stock has a market cap of $81.15 billion, a price-to-earnings ratio of 23.70, a price-to-earnings-growth ratio of 5.72 and a beta of 0.55.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.65 by $0.03. The company had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.59 billion. CME Group had a net margin of 57.34% and a return on equity of 13.39%. CME Group’s quarterly revenue was up 18.4% on a year-over-year basis. During the same quarter in the previous year, the business posted $2.25 earnings per share. Equities analysts anticipate that CME Group Inc. will post 10.23 EPS for the current year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Monday, September 9th were paid a $1.15 dividend. This represents a $4.60 dividend on an annualized basis and a yield of 2.04%. The ex-dividend date was Monday, September 9th. CME Group’s dividend payout ratio (DPR) is presently 48.37%.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on the stock. Barclays lifted their price objective on shares of CME Group from $219.00 to $231.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 24th. Citigroup raised their target price on shares of CME Group from $250.00 to $255.00 and gave the stock a “buy” rating in a report on Thursday, October 24th. Piper Sandler raised their target price on shares of CME Group from $240.00 to $250.00 and gave the stock an “overweight” rating in a report on Monday. JPMorgan Chase & Co. raised their target price on shares of CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a report on Thursday, July 25th. Finally, Oppenheimer raised their target price on shares of CME Group from $245.00 to $258.00 and gave the stock an “outperform” rating in a report on Thursday, October 24th. Four research analysts have rated the stock with a sell rating, seven have given a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $222.73.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.